Human Genome Epidemiology Literature Finder
Rare Diseases
|
Records 1 - 30 (of 758 Records) |
| Query Trace: Renal Cell Carcinoma 4[original query] |
|---|
| Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1-Associated Genes in Finnish Patients with Uveal Melanoma. Pigment cell & melanoma research 2024 9 . Pauliina E Repo, Eveliina Jakkula, Juho Hiltunen, Heidi Putkuri, Aleksandra Staskiewicz-Tuikkanen, Reetta-Stiina Järvinen, Martin Täll, Virpi Raivio, Rana'a T Al-Jamal, Tero T Kivelä, Joni A Turun |
| Pan-cancer analysis of the role of MPP7 in human tumors. Heliyon 2024 9 10 (16): e36148. Xiaotong Xu, Weyland Cheng, Shuai Zhao, Yuchun Liu, Lifeng Li, Xiaorui Song, Yaodong Zhang, Cong Di |
| Evaluation of PD-L1 expression in PBRM1-altered clear cell renal cell carcinoma. Urologic oncology 2024 9 . Jieun Lee, Seyoung Moon, Hyun Jung Kwon, Sejoon Lee, Gheeyoung Choe, Kyu Sang L |
| Prevalence of Germline Pathogenic Variants in Renal Cancer Predisposition Genes in a Population-Based Study of Renal Cell Carcinoma. Cancers 2024 9 16 (17): . Fiona Bruinsma, Philip Harraka, Susan Jordan, Daniel J Park, Bernard Pope, Jason Steen, Roger L Milne, Graham G Giles, Ingrid Winship, Katherine M Tucker, Melissa C Southey, Tu Nguyen-Dumo |
| Differences in mutations across tumour sizes in clear-cell renal cell carcinoma. BJU international 2024 9 . Steven M Monda, Benjamin W Carney, Allison M May, Shuchi Gulati, Simpa S Salami, Thenappan Chandrasekar, Evan T Keller, Nicolai A Huebner, Ganesh S Palapattu, Marc A Dall'E |
| Frequent gene mutations and the correlations with clinicopathological features in clear cell renal cell carcinoma: preliminary study based on Chinese population and TCGA database. BMC urology 2024 8 24 (1): 170. Qiang Zhao, Baoan Hong, Xuezhou Zhang, Jia Xue, Sheng Guo, Ning Zha |
| Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery. European urology oncology 2024 8 . Jennifer Ma, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic, Jessica Flynn, Zhigang Zhang, Jordan Eichholz, Sahil D Doshi, Martin H Voss, Benjamin Freeman, A Ari Hakimi, Chung-Han Lee, Tejus A Bale, Daniel Kelly, Boris A Mueller, Justin Mann, Yao Yu, Melissa Zinovoy, Linda Chen, John Cuaron, Atif Khan, Yoshiya Yamada, Jacob Y Shin, Kathryn Beal, Nelson S Moss, Maria I Carlo, Robert J Motzer, Brandon S Imber, Ritesh R Kotecha, Luke R G Pi |
| Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis. BMC cancer 2024 8 24 (1): 1059. Chao Zhou, Yunke Yang, Lu Shen, Lu Wang, Juan Zhang, Xi |
| Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism. Clinical genitourinary cancer 2024 8 102180. Sajedeh Mobaraki, Peter Henrik Nissen, Frede Donskov, Agnieszka Wozniak, Yannick Van Herck, Lina Coosemans, Tine van Nieuwenhuyse, Diether Lambrechts, Oliver Bechter, Marcella Baldewijns, Eduard Roussel, Annouschka Laenen, Benoit Beuselin |
| A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 8 . Yong-Bo Chen, Xin Yang, Dong Lv, Liang-You Tang, Ying-Wen L |
| Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme. Cureus 2024 8 16 (7): e64506. Amna Makawi, Somia A Khalafallah, Israa M Faris, Mohamed Alfa |
| The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment. Clinical and experimental medicine 2024 8 24 (1): 191. Xiaoliang Wu, Ruixin Fan, Yangjun Zhang, Chen Duan, Xiangyang Yao, Kai Liu, Dongxu Lin, Zhong Ch |
| Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024 8 128 110774. Lucca B Palavani, Raphael Camerotte, Bernardo Vieira Nogueira, Márcio Yuri Ferreira, Leonardo B Oliveira, Lucas Pari Mitre, Wilson Coelho Nogueira de Castro, Gisele Lúcia Canto Gomes, Luis F Fabrini Paleare, Sávio Batista, Filipi Fim Andreão, Raphael Bertani, Allan Dias Polveri |
| Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening. JCO precision oncology 2024 8 8 e2400094. Kate I Glennon, Mikiko Endo, Yoshiaki Usui, Yusuke Iwasaki, Rodney H Breau, Anil Kapoor, Mark Lathrop, Simon Tanguay, Yukihide Momozawa, Yasser Riazalhossei |
| Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma. Scientific reports 2024 7 14 (1): 15800. Jia Hwang, Hye Eun Lee, Jin Seon Han, Moon Hyung Choi, Sung Hoo Hong, Sae Woong Kim, Ji Hoon Yang, Unsang Park, Eun Sun Jung, Yeong Jin Ch |
| Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. Nature genetics 2024 7 . Megan Buckley, Chloé Terwagne, Athina Ganner, Laura Cubitt, Reid Brewer, Dong-Kyu Kim, Christina M Kajba, Nicole Forrester, Phoebe Dace, Joachim De Jonghe, Scott T C Shepherd, Chelsea Sawyer, Mairead McEwen, Sven Diederichs, Elke Neumann-Haefelin, Samra Turajlic, Evgueni A Ivakine, Gregory M Findl |
| A causal link between circulating leukocytes and three major urologic cancers: a mendelian randomization investigation. Frontiers in genetics 2024 7 15 1424119. Yi Zhi-Gang, Wang Han-Do |
| The causal relationship between smoking, alcohol consumption, and renal clear cell carcinoma: a Mendelian randomization study. Frontiers in genetics 2024 7 15 1391542. Hongbin Cui, Junji Du, Hongbo Xue, Yingjian Zhao, Chengwen |
| Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma. Journal of the National Cancer Center 2024 7 3 (3): 236-249. Aihetaimujiang Anwaier, Wenhao Xu, Wangrui Liu, Shiyin Wei, Xi Tian, Yuanyuan Qu, Jianfeng Yang, Hailiang Zhang, Dingwei |
| Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival. International journal of molecular sciences 2024 7 25 (13): . Anna Andrzejczak, Bartosz Ma?kiewicz, Krzysztof Tupikowski, Kuba Ptaszkowski, Tomasz Szyde?ko, Lidia Karab |
| Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics. Heliyon 2024 6 10 (11): e31816. Ruizhi Gao, Jinshu Pang, Peng Lin, Rong Wen, Dongyue Wen, Yiqiong Liang, Zhen Ma, Li Liang, Yun He, Hong Ya |
| Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 2024 6 12 918. Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortz |
| LHFPL2 Serves as a Potential Biomarker for M2 Polarization of Macrophages in Renal Cell Carcinoma. International journal of molecular sciences 2024 6 25 (12): . Xiaocheng Gong, Yunfei Liu, Qian Zhang, Keying Liang, Jinfen Wei, Hongli |
| Surgical Outcomes and Genomic Insights of Nonclear Cell Renal Cell Carcinoma with Synchronous and Metachronous Nodal Disease. Urology practice 2024 6 101097UPJ0000000000000623. Lennert Eismann, Mark Zucker, Mark T Dawidek, Stephen W Reese, Lina Posada Calderon, Andreas Aulitzky, Christian G Stief, Jonathan A Coleman, Ritesh R Kotecha, Maria Carlo, Yingbei Chen, Eduard Reznik, Paul Russo, A Ari Haki |
| A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma. Aging 2024 6 16 . Bohong Chen, Mingguo Zhou, Li Guo, Xinyue Sun, Haoxiang Huang, Kaijie Wu, Wei Chen, Dapeng |
| Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers 2024 5 16 (10): . Corbin J Eule, Junxiao Hu, Dale Hedges, Alkesh Jani, Thomas Pshak, Brandon J Manley, Alejandro Sanchez, Robert Dreicer, Zin W Myint, Yousef Zakharia, Elaine T L |
| Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome. JAMA dermatology 2024 5 . Alexandra Lebensohn, Azam Ghafoor, Luke Bloomquist, Michael C Royer, Leslie Castelo-Soccio, Kelli Karacki, Olanda Hathaway, Tenin Maglo, Cathy Wagner, Maria G Agra, Andrew M Blakely, David S Schrump, Raffit Hassan, Edward W Cow |
| Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 2024 5 . Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi E |
| Machine Learning Gene Signature to Metastatic ccRCC Based on ceRNA Network. International journal of molecular sciences 2024 4 25 (8): . Epitácio Farias, Patrick Terrematte, Beatriz Strans |
| Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan. Anticancer research 2024 4 44 (5): 1931-1938. Cheng-Hsi Liao, Wei-Ching Chien, Shu-Yu Chang, Yu-Hsin Lin, Yun-Chi Wang, Wen-Chin Huang, Mei-Chin Mong, Ya-Chen Yang, Wen-Tzu Wu, Jaw-Chyun Chen, Chao-Hsiang Chang, Chia-Wen Tsai, DA-Tian Bau, Wen-Shin Cha |
- Page last reviewed:Feb 1, 2024
- Content source: